TITLE

Lower Vaccine Prices For Developing Countries

PUB. DATE
July 2011
SOURCE
Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the move of several pharmaceutical companies to lower the prices of important vaccines for use in developing countries.
ACCESSION #
63483065

 

Related Articles

  • Drug companies cut HIV drug prices in the developing world. Yamey, Gavin // BMJ: British Medical Journal (International Edition);05/20/2000, Vol. 320 Issue 7246, p1357 

    Reports that the United Nations (UN) announced in May 2000 that several multinational pharmaceutical companies will reduce the price of HIV drugs in the developing world. GlaxoWellcome to reduce the price of its combination tablet of zidovudine and lamivudine; Views of international health...

  • Antiretroviral price reductions possible.  // PharmacoEconomics & Outcomes News;10/21/2006, Issue 514, p7 

    The article reveals that price reductions for some antiretrovirals, purchased by developing countries, is possible according to a study conducted by multinational researchers. Price decreases will depend on future costs of active pharmaceutical ingredients, but could be realized if indirect cost...

  • An AIDS Drug-Price War. Guterl, Fred; Margolis, Mac; Mazumdar, Sudip; Masland, Tom; Suterwalla, Shehnaz // Newsweek (Atlantic Edition);02/19/2001 (Atlantic Edition), Vol. 137 Issue 8, p53 

    Discusses the decision of Indian drugmaker Cipla to cut prices on its anti-AIDS drugs in developing countries. The effect which this is having on the worldwide pharmaceutical industry; Cipla's distribution of the drugs through the organization Medecins sans frontieres; Patent-law issues.

  • Big Pharma has a heart after all.  // New Scientist;2/21/2009, Vol. 201 Issue 2696, p6 

    This article states that GlaxoSmithKline (GSK) has announced a host of measures to make medicines more available to the world's poor, raising hopes that its rivals will do the same. In a speech at Harvard Medical School on 13 February, the chairman of GSK, Andrew Witty, declared that his company...

  • Paying for AIDS Cocktails. McGeary, Johanna; Branegan, Jay; Dowell, William; Park, Alice // Time International (South Pacific Edition);2/12/2001, Issue 6, p43 

    Comments on drug firms' arguments for keeping the price of drugs used for AIDS chemotherapy high, despite the need for inexpensive treatment in Third World countries like Africa. Issues of compulsory licensing and generics; Fear of the pharmaceutical industry that Western markets will demand...

  • The BRIC Countries. Kuhrt, Kate // Pharmaceutical Technology;Aug2008 Supplement, p22 

    The article outlines the opportunities and challenges faced by active pharmaceutical ingredients (API) and finished-dose manufacturers upon entering the emerging market of Brazil, Russia, India, and China (BRIC) countries. The emerging markets in BRIC countries have already left footprints on...

  • Cut-Rate AIDS. Golden, Frederic // Time International (South Pacific Edition);3/19/2001, Issue 11, p56 

    Reports on the need for lower prices for combination-drug therapy for AIDS disease in developing countries. Efforts of pharmaceutical companies to avoid cutting prices and keeping generic copies of their drugs out of South Africa; Decision of Merck and other drug companies to cut prices for...

  • Paying for AIDS Cocktails. McGeary, Johanna; Branegan, Jay; Dowell, William; Park, Alice // Time;2/12/2001, Vol. 157 Issue 6, p54 

    Comments on drug firms' arguments for keeping the price of drugs used for AIDS chemotherapy high, despite the need for inexpensive treatment in Third World countries like Africa. Issues of compulsory licensing and generics; Fear of the pharmaceutical industry that Western markets will demand...

  • International drug price comparisons: quality assessment. Machado, M├írcio; O'Brodovich, Ryan; Krahn, Murray; Einarson, Thomas R. // Pan American Journal of Public Health;Jan2011, Vol. 29 Issue 1, p46 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics